Curi Bio
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $10M
Investors
- 3
About Curi Bio
, formerly NanoSurface Biomedical develops integrating human cells, systems, and data. In December 2025, Curi Bio, Inc. Curi Bio, Inc. provides a discovery platform that combines human stem cells, systems, and data in discovering new medicines. The firm also provides technologies and products that include NanoSurface Plates for structural maturation, Cytostretcher cell-stretching instruments, and Mantarray for 3D tissue contractility analysis, and it specializes in cardiac, musculoskeletal, and neuromuscular models.
Who invested in Curi Bio
3 investors across 2 rounds
See all investors in Curi Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Curi Bio
Who invested in Curi Bio?
Curi Bio has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Curi Bio raised?
Curi Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Curi Bio last raise money?
Curi Bio's most recent round on record is a Series A, in Dec 2021.
What does Curi Bio do?
, formerly NanoSurface Biomedical develops integrating human cells, systems, and data.
Where is Curi Bio headquartered?
Curi Bio is headquartered in Seattle, US.
Which VCs invest in companies like Curi Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Curi Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Curi Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.